Aligos Therapeutics Inc
(ALGS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 42,056 | 18,771 | 73,873 | 37,107 | 35,441 |
| Marketable Securities | 57,150 | 104,284 | 64,098 | 19,942 | 39,591 |
| Other current assets | 4,229 | 4,889 | 5,234 | 5,092 | 4,790 |
| TOTAL | $103,435 | $127,944 | $143,205 | $62,141 | $79,822 |
| Non-Current Assets | |||||
| PPE Net | 2,035 | 2,063 | 2,214 | 2,362 | 2,575 |
| Other Non-Current Assets | 4,294 | 4,699 | 5,280 | 5,591 | 6,029 |
| TOTAL | $6,329 | $6,762 | $7,494 | $7,953 | $8,604 |
| Total Assets | $109,764 | $134,706 | $150,699 | $70,094 | $88,426 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,651 | 3,937 | 4,460 | 2,571 | 2,740 |
| Accrued Expenses | 13,605 | 12,209 | 11,001 | 15,557 | 14,161 |
| TOTAL | $21,987 | $20,265 | $18,948 | $21,737 | $20,956 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 168 | 579 | N/A | 151 | 655 |
| Other Non-Current Liabilities | 15,822 | 12,453 | 15,184 | 77,208 | 17,186 |
| TOTAL | $15,944 | $12,575 | $15,306 | $77,330 | $17,374 |
| Total Liabilities | $37,931 | $32,840 | $34,254 | $99,067 | $38,330 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 6,154 | 6,151 | 6,115 | 6,114 | 3,588 |
| Common Shares | 9 | 9 | 9 | 8 | 8 |
| Retained earnings | -622,320 | -590,783 | -574,920 | -618,008 | -535,858 |
| Other shareholders' equity | 455 | 420 | 447 | 451 | 577 |
| TOTAL | $71,833 | $101,866 | $116,445 | $-28,973 | $50,096 |
| Total Liabilities And Equity | $109,764 | $134,706 | $150,699 | $70,094 | $88,426 |